Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes
The Internet Journal of Endocrinology · 2010
DOI: 10.5580/1590 ↗At a glance
Journal article in The Internet Journal of Endocrinology, 2010.
Topics: Diabetes mellitus
Abstract (original language)
Objective
We sought to study the optimal management of hyperglycemia in non– intensive care unit patients with type 2 diabetes, as few studies so far have focused on this subject. Materials & Methods: We conducted a retrospective study to compare the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in patients with type 2 diabetes. A total of 104 patients were included in this study.
Results
Patients treated with basal insulin regimen had better glycemic control than those treated with SSI. The mean hospital length of stay was shorter in patients treated with basalbolus as compared to the SSI-treated group. The mean glucose concentration during the last day of hospitalization was significantly higher in patients treated with SSI compared with those treated with the basal-bolus regimen At the same time, mean daily dose of insulin was significantly higher in the basal-bolus regimen compared with that in the SSI treatment group.
Conclusion
Treatment with basal bolus insulin regimen resulted in significant improvement in glycemic control compared with that achieved with the use of SSI alone. Our study indicates that a basal-bolus insulin regimen should be preferred over SSI in the management of non– critically ill, hospitalized patients with type 2 diabetes.
Cite
APA
(2010). Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes. The Internet Journal of Endocrinology. https://doi.org/10.5580/1590
Vancouver
Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes. The Internet Journal of Endocrinology. 2010. doi:10.5580/1590
BibTeX
@article{euvimed2010,
title = {Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes},
journal = {The Internet Journal of Endocrinology},
year = {2010},
doi = {10.5580/1590}
}
EUVIMED